Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled adjunctive SPM927 trial in partial seizures
2004-000290-58Phase 3
- Sponsor
- Schwarz Pharma
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lacosamide in Focal onset seizure (3 arms), sponsored by Schwarz Pharma. Primary endpoint: Responder rate.
02
Drugs
lacosamide
03
Conditions
Focal onset seizure
Beyond the preview
Go deeper on 2004-000290-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000290-58.